Zeair Samir, Butkiewicz Filip, Butkiewicz Jacek, Stasiuk Robert
Department of General and Transplant Surgery, Marie Curie Regional Hospital, Szczecin, Poland.
Ann Transplant. 2017 Dec 1;22:719-724. doi: 10.12659/aot.905331.
BACKGROUND Standard methods for endoscopic retrograde cholangiopancreatography (ERCP) management of anastomotic strictures (AS) after OLT includes repeated balloon dilation of the stricture with subsequent insertion of a plastic biliary stent (PBS). In post-OLT patients not responding to standard endoscopic treatment, the placement of fully covered self-expanding metal stents (FCSEMS) is a valid alternative to surgical treatment. The aim of this study was to compare the results of new FCSEMS implantation with the standard ERCP stricture management protocol and with conventional FCSEMS insertion. MATERIAL AND METHODS This retrospective study involved 39 post-OLT patients with confirmed diagnosis of biliary AS. Enrolled subjects were divided into 2 groups: the FCSEMS group (study group) and the PBS group (control group). The study group was divided into 2 subgroups: the conventional FCSEMS group and the new-type FCSEMS group. RESULTS Stricture recurrence after PBS placement was observed in 36.36% of controls and in only 9.52% of study group members (P=0.170). Recurrence rates in patients after conventional FCSEMS and new type FCSEMS implantation was similar (10% vs. 9.09%; P=0.501). The applied treatment was successful in 82.61% of study group members and only 43.75% of controls (P=0.029). Success rates of conventional FCSEMS and new-type SEMS insertion did not differ significantly (81.82% vs. 83.33%, P=0.649). There was no statistically significant difference in complication rates between groups (P=0.879). CONCLUSIONS Implantation of FCSEMS is more effective than repeated balloon dilatation of AS with subsequent PBS placement and is they have similar complication rates. Application of new-type FCSEMS gives results comparable to conventional FCSEMS.
肝移植术后吻合口狭窄(AS)的内镜逆行胰胆管造影(ERCP)标准治疗方法包括反复对狭窄部位进行球囊扩张,随后置入塑料胆管支架(PBS)。对于肝移植术后对标准内镜治疗无反应的患者,置入全覆膜自膨式金属支架(FCSEMS)是手术治疗的有效替代方法。本研究的目的是比较新型FCSEMS植入术与标准ERCP狭窄治疗方案以及传统FCSEMS置入术的效果。
这项回顾性研究纳入了39例确诊为胆管AS的肝移植术后患者。入选患者分为2组:FCSEMS组(研究组)和PBS组(对照组)。研究组又分为2个亚组:传统FCSEMS组和新型FCSEMS组。
对照组中36.36%的患者在置入PBS后出现狭窄复发,而研究组中仅9.52%的患者出现狭窄复发(P = 0.170)。传统FCSEMS和新型FCSEMS植入术后患者的复发率相似(10%对9.09%;P = 0.501)。研究组82.61%的患者治疗成功,而对照组仅43.75%的患者治疗成功(P = 0.029)。传统FCSEMS和新型SEMS置入术的成功率无显著差异(81.82%对83.33%,P = 0.649)。各组之间的并发症发生率无统计学显著差异(P = 0.879)。
FCSEMS植入术比反复对AS进行球囊扩张并随后置入PBS更有效,且并发症发生率相似。新型FCSEMS的应用效果与传统FCSEMS相当。